Photo of Sam Montaño
D Massachusetts House · District 15th Suffolk On the 2026 ballot

Rep. Sam Montaño

Compare
Total votes
435
all sessions
Attendance
97%
14 missed
Near the chamber average
With party
99%
of cast votes
Near the chamber average
Bipartisan score
0%
crosses aisle rarely
Near the chamber average
Sponsored
1,073
bills & resolutions
Higher than 96% of chamber peers
Committees
6
assignments
1,073 bills and resolutions

Sponsored bills

Total
1,073
Primary
34
Co-sponsor
1,039
This page
1,073
matching current filters
Co-sponsor H 639
Passed · Massachusetts House · Co-sponsor
An Act increasing awareness of community based PACE programs for older adults

Maddy summaryThis bill requires Massachusetts state agencies to inform older adults about the Program of All-Inclusive Care for the Elderly (PACE), a community-based healthcare option. Specifically, it mandates that information about PACE be included in existing referral services and pre-admission counseling for individuals seeking long-term care facilities. Additionally, the legislation directs state officials to study how Medicaid providers can offer this counseling and requires an annual report on how many people received these services and how many were diverted from institutional care to community settings.

Passed Dec 21, 2023 1 co-sponsor
Primary H 3090
Passed · Massachusetts House · Lead sponsor
An Act designating September as PCOS awareness month

By Representative Montaño of Boston, a petition (accompanied by bill, House, No. 3090) of Samantha Montaño, Jason M. Lewis and Hannah Kane for the annual issuance of a proclamation by the Governor setting apart the month of September as polycystic ovary syndrome awareness month. State Administration and Regulatory Oversight.

Passed Nov 22, 2023 0 co-sponsors
Co-sponsor S 2492
Passed · Massachusetts Senate · Co-sponsor
An Act relative to pharmaceutical access, costs and transparency

Senate, October 30, 2023 -- The committee on Health Care Financing, to whom was referred the petitions (accompanied by bill, Senate, No. 732) of John J. Cronin for legislation to promote comprehensive transparency in the pharmaceutical industry; (accompanied by bill, Senate, No. 749) of Cindy F. Friedman, Rebecca L. Rausch, Susannah M. Whipps, Joanne M. Comerford and other members of the General Court for legislation relative to pharmaceutical access, costs and transparency; (accompanied by bill, Senate, No. 767) of Jason M. Lewis for legislation to define modest meals and refreshments in prescriber education settings; (accompanied by bill, Senate, No. 778) of Paul W. Mark for legislation to bring down the cost of prescription drugs; (accompanied by bill, Senate, No. 783) of Mark C. Montigny and Michael J. Barrett for legislation to promote transparency and prevent price gouging of pharmaceutical drug prices; (accompanied by bill, Senate, No. 784) of Mark C. Montigny for legislation relative to coverage for chronic illness; (accompanied by bill, Senate, No. 797) of Jacob R. Oliveira for legislation to bring down the cost of prescription drugs; (accompanied by bill, House, No. 619) of Nicholas A. Boldyga relative to establishing a prescription drug rebate program for seniors; (accompanied by bill, House, No. 1176) of Edward F. Coppinger and others relative to promoting comprehensive transparency in the pharmaceutical industry; (accompanied by bill, House, No. 1201) of Kate Hogan relative to the pricing of prescription drugs; (accompanied by bill, House, No. 1205) of Bradley H. Jones, Jr., and others that the Health Policy Commission and health insurers create listings of certain high cost prescription drugs and that the Attorney General require drug manufacturers to provide information to justify increases in costs; (accompanied by bill, House, No. 1206) of Bradley H. Jones, Jr., and others for an investigation by a special commission (including members of the General Court) relative to contracts between the MassHealth program and pharmaceutical benefit managers; (accompanied by bill, House, No. 1215) of John J. Lawn, Jr., and others relative to pharmacy benefit managers; (accompanied by bill, House, No. 1246) of William M. Straus relative to drug prices paid by carriers; and (accompanied by bill, House, No. 1247) of Alyson M. Sullivan-Almeida, Michael J. Soter and David F. DeCoste relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth, reports the accompanying bill (Senate, No. 2492).

Passed Nov 15, 2023 1 co-sponsor
Co-sponsor H 1168
Passed · Massachusetts House · Co-sponsor
An Act protecting the homes of seniors and disabled people on MassHealth

Maddy summaryThis bill modifies Massachusetts law to limit when the state can recover medical assistance costs from the estates of seniors and disabled individuals, aiming to protect their homes from being seized to pay for past care. Under the new rules, the state can only seek repayment after the death of a surviving spouse and only if there are no surviving children under 21 or with disabilities. Additionally, the legislation expands the age threshold for recovery from 65 to 55 for certain services provided after October 1, 1993, while maintaining protections for those who were permanently institutionalized. The law also mandates that the state must waive recovery efforts if doing so would cause undue hardship.

Passed Oct 30, 2023 1 co-sponsor
Co-sponsor H 1176
Passed · Massachusetts House · Co-sponsor
An Act relative to promoting comprehensive transparency in the pharmaceutical industry

Maddy summaryThis bill amends Massachusetts state law to increase transparency within the pharmaceutical industry by adding new definitions for key industry players. It specifically defines "pharmaceutical manufacturing companies," "pharmacy benefit managers," "pipeline drugs," and "sponsors" to clarify who must comply with reporting requirements. The legislation also expands the group of entities responsible for paying fees to the state commission, ensuring that costs for analyzing drug spending trends are fully covered by these companies and managers. By updating existing statutes, the bill aims to improve data collection on pharmaceutical expenditures without introducing new regulatory mandates beyond these definitional and fee-related changes.

Passed Oct 30, 2023 1 co-sponsor
Co-sponsor H 3019
Passed · Massachusetts House · Co-sponsor
An Act establishing gender-neutral bathrooms

By Representative Domb of Amherst, a petition (accompanied by bill, House, No. 3019) of Mindy Domb and others relative to the promulgation of State Building Code regulations to allow for gender-neutral bathrooms. State Administration and Regulatory Oversight.

Passed Oct 30, 2023 1 co-sponsor
Co-sponsor H 1237
Passed · Massachusetts House · Co-sponsor
An Act to ensure equitable health coverage for children

Maddy summaryThis bill creates a new health coverage program for children and young adults under 21 in Massachusetts who currently lack access to MassHealth solely because of their immigration status. It allows these individuals to receive comprehensive health benefits similar to those available to other residents who meet standard income and age requirements, regardless of whether they qualify for federal funding. The law mandates that the state maximize available federal money for these benefits but ensures that eligibility is not dependent on receiving that federal support.

Passed Oct 30, 2023 1 co-sponsor
Showing 1,031 to 1,040 of 1,073 bills